Artificial intelligence has benefited clinicians and users of the Coapt Gen2® system since 2019.
Learn how in Miles O’Brien’s segment with Blair Lock on this episode of NOVA on PBS.
This study underscores the Coapt system as a groundbreaking technology that serves myoelectric users across the entire spectrum of control preferences, offering truly personalized solutions.
Todd Farrell, Ph.D. named CEO of Liberating Technologies, Inc.
WillowWood Global LLC (“WillowWood”) announces release of Alpha Control Liner System in collaboration with Coapt LLC, the first prosthetic liner with embedded electronics.
Department of Defense Awards Tech Firm Coapt $2.3M to Develop Virtual Reality-based Therapy to Ease Phantom Limb Pain
Coapt expands its research and development capabilities by acquiring Liberating Technologies, Inc. (LTI).
Whether upper-limb difference is the result of an illness, injury or birth complication, the needs of those wearing upper-limb prosthetic devices can vary quite a bit.
In the roughly 100 years since prostheses were first widely produced to meet the needs of injured World War I veterans, artificial limbs have grown ever-more sophisticated.
AMSE gives examples of how technology is improving prosthetics and with it people’s lives.AMSE gives examples of how technology is improving prosthetics and with it people’s lives.
Coapt Expands Global Distribution